Savoy, IL, United States of America

Ping Cao


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ping Cao in Anti-Neoplastic Therapy

Introduction

Ping Cao is an accomplished inventor based in Savoy, Illinois, known for his significant contributions to the field of therapeutics. He holds a patent that focuses on anti-neoplastic compounds, which are crucial in the fight against cancer. His work is particularly relevant in the development of therapies that inhibit cysteine proteases, which play a role in various therapeutic regimes.

Latest Patents

Ping Cao's most notable patent is titled "Anti-neoplastic compounds, compositions and methods." This patent discloses novel compounds that are useful as therapeutics, especially in anti-neoplastic therapy. The compounds developed by Cao have the potential to make a significant impact in cancer treatment and other related therapeutic areas.

Career Highlights

Cao is currently associated with Progenra, Inc., a company that focuses on innovative therapeutic solutions. His work at Progenra has allowed him to explore and develop new compounds that can lead to advancements in medical treatments. With one patent to his name, he has established himself as a valuable contributor to the field of medicinal chemistry.

Collaborations

Throughout his career, Ping Cao has collaborated with notable colleagues such as Joseph Weinstock and William Kingsbury. These collaborations have likely enriched his research and contributed to the development of effective therapeutic strategies.

Conclusion

Ping Cao's innovative work in anti-neoplastic therapy highlights his commitment to advancing medical science. His contributions through patents and collaborations demonstrate the importance of research in developing new treatments for cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…